ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA advisory panel votes against approval of Johnson & Johnson's experimental RA drug Plivensia
August 03, 2017Johnson & Johnson announced Wednesday that an FDA advisory panel voted against recommending approval of its experimental rheumatoid arthritis (RA) therapy Plivensia (sirukumab). Citing safety concerns, the panel voted 12 to 1 that the benefits of the drug
Pharma Sources Insight January 2025
